Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on SUCAMPO PHARMACEUTICALS, I
11/09/17 Q3 2017 Earnings Release (Projected)
03/07/18 FY 2017 Earnings Release (Projected)
Past events on SUCAMPO PHARMACEUTICALS, I
10/04/17 | 10:15pm Deutsche Bank U.S. Leveraged Finance Conference
09/27/17 | 09:30pm LEERINK Partners Rare Disease & Immuno-Oncology Conference
09/26/17 | 05:30pm Cantor Fitzgerald Global Healthcare Conference
09/06/17 | 08:25pm Wells Fargo Securities Health Care Conference
Upcoming sector events for SUCAMPO PHARMACEUTICALS, I
10/25/17 GILEAD SCIENCES, INC. : European AIDS Conference
10/25/17 PRA HEALTH SCIENCES INC : Q3 2017 Earnings Release
10/26/17 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. : Q3 2017 Earnings Release
10/26/17 | 10:30pm SEATTLE GENETICS, INC. : Q3 2017 Earnings Call
Past sector events for SUCAMPO PHARMACEUTICALS, I
09/28/17 GALAPAGOS NV : KBC Biotech and Healthcare Conference
09/28/17 | 02:00pm TESARO INC : LEERINK Partners Rare Disease & Immuno-Oncology Conference
09/28/17 | 03:30pm BLUEBIRD BIO INC : LEERINK Partners Rare Disease & Immuno-Oncology Conference
10/10/17 | 09:15pm BLUEBIRD BIO INC : Chardan Gene Therapy Conference
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million $
Released
Forecast
Spread
115
115
0,74%
153
141
9,0%
230
223
3,1%

234

246
Operating income (EBITDA)
Million $
Released
Forecast
Spread
33,6
38,6
-13%
56,5
56,5
-0,11%
118
115
2,7%

110

113
Operating profit (EBIT)
Million $
Released
Forecast
Spread
32,5
31,3
3,8%
55,9
51,2
9,0%
107
107
-0,38%

37,6

94,5
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
13,1
15,4
-15%
33,4
28,3
18%
18,5
17,7
4,7%

-40,0

53,0
EPS
 $
Released
Forecast
Spread
0,29
0,28
3,6%
0,73
0,61
19%
0,42
0,49
-14%

-2,25

0,76
Announcement Date03/04/201503/08/201603/08/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2016
Q1
2017
Q2
2017
Q3
2017 (e)
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
73,0
66,0
11%
56,3
54,1
4,0%
59,9
56,4
6,2%

58,0

60,5
Operating income (EBITDA)
Million $
Released
Forecast
Spread
42,8
38,0
13%
28,0
30,7
-8,9%
27,4
27,1
1,2%

27,2

29,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
40,7
37,4
8,9%
25,5
27,3
-6,6%
20,9
23,5
-11%

21,1

23,4
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
15,3
14,5
5,7%
4,62
13,1
-65%
-181
7,95
-2 380%

7,76

9,97
EPS
 $
Released
Forecast
Spread
0,34
0,42
-19%
0,10
0,16
-36%
-3,92
0,17
-2 362%

0,10

0,17
Announcement Date03/08/201705/03/201708/02/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise